What happened
According to an SEC filing dated May 15, 2026, Rubicon Founders LLC increased its holdings in Privia Health Group (NASDAQ:PRVA) by 175,142 shares during the first quarter. The estimated transaction value was $3.95 million, calculated using the average closing prices for the quarter. The quarter-end value of the position fell by $14.53 million, a figure that reflects both the trading activity and changes in share price.
What else to know
Rubicon Founders’ post-trade position in Privia Health Group means the stock now represents 88.92% of 13F reportable AUM.
Top holdings after the filing:
NASDAQ: PRVA: $122.36 million (88.92% of AUM)
NYSE: EVH: $13.26 million (9.64% of AUM)
NYSE: AGL: $1.99 million (1.45% of AUM)
As of May 14, 2026, shares of Privia Health Group were priced at $23.24, down 4.4% over the past year, trailing the S&P 500 by 31.66 percentage points.
Company overview
Metric | Value |
|---|---|
Revenue (TTM) | $2.25 billion |
Net income (TTM) | $21.76 million |
Market capitalization | $2.94 billion |
Price (as of market close May 14, 2026) | $23.24 |
Company snapshot
Privia Health Group offers technology solutions, population health tools, and management services to optimize physician practices and enhance patient care, generating revenue primarily from physician enablement and value-based care services.
It operates a physician-enablement platform and management services organization that facilitates clinical integration, payer negotiations, and administrative support, monetizing through service fees and value-based contracts.
The company serves independent providers, medical groups, health plans, and health systems across the United States, targeting healthcare organizations seeking efficiency and improved patient outcomes.
Privia Health Group is a national healthcare platform specializing in physician enablement and value-based care solutions. The company leverages technology and coordinated care models to support independent providers and medical groups, driving operational efficiency and improved patient experiences.
With a scalable business model and a focus on aligning financial incentives, Privia Health positions itself as a strategic partner for healthcare organizations navigating the shift to value-based care.
What this transaction means for investors
Rubicon Founders increasing its stake in Privia Health Group during the first quarter is a noteworthy event for investors. It demonstrates the hedge fund has a bullish outlook towards the stock, so much so that Privia Health now represents nearly 90% of the firm’s AUM. As a result, the fund’s performance depends almost entirely on this one stock.
